Big Move For TRACON Pharmaceuticals, Inc.
Thu, Jan 16, 2020 at 05:30 PM
TRACON Pharmaceuticals, Inc. (TCON:NASDAQ) rocketted at $4.3, a gain of 46.8%. On Wed 15 Jan 20, TCON:NASDAQ hit a New 2-Week High of $2.93. The stock got featured on our News Catalysts scanner on Fri 20 Dec 19 at 09:36 AM in the 'PATNERSHIP' category. From Tue 24 Dec 19, the stock recorded 64.29% Up Days and 46.67% Green Days
The share price of the company has been moving sideways in recent weeks.
About TRACON Pharmaceuticals, Inc. (TCON:NASDAQ)
TRACON Pharmaceuticals Inc is a clinical stage biopharmaceutical company. The Company is engaged in the development and commercialization of novel targeted therapeutics for cancer, age-related macular degeneration and fibrotic diseases.
Top 10 Gainers:
- The McClatchy Company (MNI:NASDAQ), 241.84%
- Aethlon Medical, Inc. (AEMD:NASDAQ), 57.71%
- TRACON Pharmaceuticals, Inc. (TCON:NASDAQ), 46.76%
- Internap Corporation (INAP:NASDAQ), 40.86%
- PolarityTE, Inc. (PTE:NASDAQ), 40.51%
- Signet Jewelers Limited (SIG:NYSE), 40.2%
- NantKwest, Inc. (NK:NASDAQ), 39.25%
- Neon Therapeutics, Inc. (NTGN:NASDAQ), 38.21%
- Cemtrex, Inc. (CETX:NASDAQ), 37.91%
- Proteon Therapeutics, Inc. (PRTO:NASDAQ), 30.5%